New Age Thinking: US FDA’s Temple Sees Third Era Of Drug Development
• By Michael McCaughan
Official notes significant under-appreciated changes in areas like the assessment of drug-drug interactions, metabolic response to therapeutics, and willingness for sub-population analyses. • Source: Shutterstock
